Wnt activation is implicated in glioblastoma radioresistance (Q34232635)

31 July 2017

title

Wnt activation is implicated in glioblastoma radioresistance (English)

1 reference

31 July 2017

1 reference

1

Yonghyun Kim

1 reference

31 July 2017

Kang Ho Kim

2

1 reference

31 July 2017

Jeena Lee

3

1 reference

31 July 2017

Young-Ae Lee

4

1 reference

31 July 2017

Misuk Kim

5

1 reference

31 July 2017

Se Jeong Lee

6

1 reference

31 July 2017

Kernyu Park

7

1 reference

31 July 2017

Heekyoung Yang

8

1 reference

31 July 2017

Juyoun Jin

9

1 reference

31 July 2017

Kyeung Min Joo

10

1 reference

31 July 2017

Jeongwu Lee

11

1 reference

31 July 2017

Do-Hyun Nam

12

1 reference

31 July 2017

publication date

14 November 2011

1 reference

31 July 2017

published in

Laboratory Investigation

1 reference

31 July 2017

volume

92

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

466-473

1 reference

Identification of human brain tumour initiating cells

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

A2B5 cells from human glioblastoma have cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Integrin alpha 6 regulates glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Microenvironmental regulation of glioblastoma radioresponse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Prospective identification of cancer stem cells with the surface antigen CD133.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Clonogenic assay of cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Mitochondrial DNA Integrity Is Essential For Mitochondrial Maturation During Differentiation of Neural Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Rembrandt: helping personalized medicine become a reality through integrative translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Tissue repair and stem cell renewal in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Targeting Wnt signaling in colon cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

β-catenin and Gli1 are prognostic markers in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Cancer treatments transform residual cancer cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Alternative lengthening of telomeres in human glioma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Oncolytic adenoviruses targeted to cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

Cancer stem cells and their mechanism of chemo-radiation resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.161

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2011.161

1 reference

Dimensions Publication ID

31 July 2017

1036834542

0 references

1 reference